The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study.

Autor: Presl, Jiri1 (AUTHOR) preslj@fnplzen.cz, Havelka, Pavel2 (AUTHOR) havelka@bnzlin.cz, Weinberger, Vit3 (AUTHOR) weinberger.vit@fnbrno.cz, Ovesna, Petra4 (AUTHOR) ovesna@iba.muni.cz, Fekete, Peter5 (AUTHOR) peter.fekete@ousa.sk, Fruhauf, Filip6 (AUTHOR) filip.fruhauf@vfn.cz, Jedryka, Marcin7 (AUTHOR) mjedryka@interia.pl, Bystricky, Branislav8 (AUTHOR) branislav.bystricky@fntn.sk, Strojna, Aleksandra9,10 (AUTHOR) ola.strojna@yahoo.com, Volodko, Nataliya11 (AUTHOR) nvolodko@yahoo.com, Matylevich, Olga12 (AUTHOR) omatylevich@tut.by, Herboltova, Petra13,14 (AUTHOR) petraherb@email.cz, Blecharz, Pawel15 (AUTHOR) pawel.blecharz@interia.pl, Kalist, Vladimir2 (AUTHOR) vladimir.kalist@bnzlin.cz, Ehrlichova, Lucie16 (AUTHOR) ehrlichova.lucie@fnbrno.cz, Stranik, Petr1 (AUTHOR) smoligovav@fnplzen.cz, Masak, Ladislav5 (AUTHOR) ladislav.masak@ousa.sk, Poncova, Renata6 (AUTHOR) renata.poncova@vfn.cz, Czekanski, Andrzej7 (AUTHOR) andrzej.czekanski@gmail.com, Chaloupkova, Barbora2 (AUTHOR) barbora.chaloupkova@bnzlin.cz
Zdroj: Cancers. Nov2024, Vol. 16 Issue 21, p3566. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje